CAS NO: | 1210608-43-7 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | PIM447 (LGH447) is a potent, orally available, and selective pan-PIMkinaseinhibitor, withKivalues of 6, 18, and 9 pM forPIM1,PIM2, andPIM3, respectively. PIM447 displays dual antimyeloma and bone-protective effects. PIM447 inducesapoptosis[1][2]. | ||||||||||||||||
体外研究 (In Vitro) | PIM447 (0.05-10 μM; 24-72 hours) shows antiproliferative effect on the multiple myeloma (MM) cells[2]. Cell Viability Assay[2]
Western Blot Analysis[2]
| ||||||||||||||||
体内研究 (In Vivo) | PIM447 (100 mg/kg; p.o.; 5 times for a week) reduces tumor burden[2].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 440.46 | ||||||||||||||||
Formula | C24H23F3N4O | ||||||||||||||||
CAS 号 | 1210608-43-7 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |